Pricing Log in Create free account

Bolt Biotherapeutics, Inc. (BOLT) vs Psyence Biomedical Ltd. (PBM)

Bolt Biotherapeutics, Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and Psyence Biomedical Ltd. are of similar size ($12.3M and $11.2M). Bolt Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.1×. Psyence Biomedical Ltd. has the higher net margin (0.00% vs −611.5%) and the higher return on invested capital (0.00% vs −143.8%). Across the 12 metrics below, Psyence Biomedical Ltd. leads on 9 and Bolt Biotherapeutics, Inc. on 3.

Valuation

Metric BOLT PBM Biotechnology median
P/E n/m 0.13 10.26
P/S 2.35 n/m 9.18
P/B 0.87 0.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 1.91 0.65
EV/Sales 2.51 n/m 8.98
Earnings yield (251.76%) 759.84% (34.89%)
Free cash flow yield (279.10%) (1,147.64%) (24.52%)

Profitability

Metric BOLT PBM Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (654.53%) — 0.00%
Net margin (611.47%) 0.00% 0.00%
Free cash flow margin (655.72%) 0.00% 0.00%
Return on equity (111.65%) (23.52%) (50.12%)
Return on assets (49.62%) (6.74%) (45.60%)
Return on invested capital (143.75%) 0.00% 0.00%

Growth

Metric BOLT PBM Biotechnology median
Revenue growth (TTM) 12.79% — 6.26%
EPS growth (last fiscal year) 45.91% (138.35%) 29.88%
Revenue growth, 5-year CAGR 101.61% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BOLT PBM Biotechnology median
Debt to equity 1.47 0.00 0.00
Current ratio 2.61 8.09 4.89
Net debt to EBITDA 0.21 1.20 1.01

Dividend

Metric BOLT PBM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BOLT PBM Biotechnology median
Market cap 12.29m 11.21m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack